COVID-19: Post-recovery Manifestations

Background Post-COVID-19 syndrome, also known as long COVID, is a disorder that has many characteristics, one of which is chronic fatigue following acute infection with the SARS-CoV-2 virus. Methodology We distributed a web-based survey among patients diagnosed with COVID-19 across the world and collected 190 responses regarding their demographics, histories, COVID-19 infection courses, and common symptoms. Results We found that about 85.3% of the patients experienced some form of symptom following recovery from the infection. Among the reported symptoms, 59% of patients experienced fatigue or lethargy, 48.9% reported decreased stamina, 32.6% reported shortness of breath, 16.8% had a persistent cough, and 23.7% experienced anxiety following recovery from COVID-19. Conclusions Reported symptoms closely resembled myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, a deeper biochemical understanding of ME/CFS is required to confirm causation.

[1]  M. Theodoridou,et al.  Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals , 2021, Archives of Medical Research.

[2]  C. Fernández‐de‐las‐Peñas,et al.  Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification , 2021, International journal of environmental research and public health.

[3]  C. Ryerson,et al.  Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea , 2021, Respiratory Physiology & Neurobiology.

[4]  Liang Wang,et al.  Demographic, signs and symptoms, imaging characteristics of 2126 patients with COVID-19 pneumonia in the whole quarantine of Wuhan, China , 2021, Clinical Imaging.

[5]  Felipe García,et al.  Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain , 2021, The Lancet Regional Health - Europe.

[6]  A. Komaroff,et al.  Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? , 2021, Frontiers in Medicine.

[7]  P. Wostyn.  COVID-19 and chronic fatigue syndrome: Is the worst yet to come? , 2021, Medical Hypotheses.

[8]  E. Wood,et al.  Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’? , 2020, Chronic Diseases and Translational Medicine.

[9]  K. Dua,et al.  Smoking and COVID-19: What we know so far , 2020, Respiratory Medicine.

[10]  N. Marx,et al.  Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae , 2020, Respiratory Medicine.

[11]  S. Merler,et al.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.

[12]  R. Chang,et al.  Sickness: From the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons , 2015, Neuroscience & Biobehavioral Reviews.

[13]  T. Ganiats.  Redefining the Chronic Fatigue Syndrome , 2015, Annals of Internal Medicine.

[14]  ChronicFatigue Syndrome.  Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2015 .

[15]  R. Dantzer,et al.  The neuroimmune basis of fatigue , 2014, Trends in Neurosciences.

[16]  K. Friedman.  Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. , 2015, Military medicine.

[17]  A. Aplogan,et al.  From the Centers for Disease Control and Prevention , 2015 .

[18]  M. Vella-Baldacchino,et al.  Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) , 2014 .

[19]  D. McGinty,et al.  Myalgic Encephalomyelitis Chronic Fatigue Syndrome (ME/CFS) , 2007 .